IRF4 and adult T-cell leukemia/lymphoma: Antisense oligonucleotides (ASOs) that directly target IRF4 messenger RNA were used to silence IRF4 gene expression in ATLL cell lines, primary patient-derived ATLL cells, and control cell T-cell lines.